IJSRP, Volume 4, Issue 12, December 2014 Edition [ISSN 2250-3153]
Sanjeev Kumar, G K Aneja, Arvind Trivedi, V Atam, Abhishek Singh, Neetu Verma Ajay Panwar, Pradeep Kumar
Cardiovascular diseases like congestive heart failure, coronary artery disease, myocardial infarction account for highest mortality in diabetic patient. Left ventricular hypertrophy which is an ominous prognostic sign and independent risk factor for cardiac events is often present along with left ventricular diastolic dysfunction (LVDD) in type 2 diabetes mellitus patients. the aim of the present study is to verify whether HbA1c detect pre-clinical diastolic dysfunction in type-2 diabetic patients. Total 100 patients of newly diagnosed type 2 diabetes mellitus were selected for this cross sectional study. Patients of age between 30 to 60 yrs were selected for the study.
Sanjeev Kumar, G K Aneja, Arvind Trivedi, V Atam, Abhishek Singh, Neetu Verma Ajay Panwar, Pradeep Kumar (2018); Glycosylated Hemoglobin (HbA1c) is a reliable Predictor of left ventricular hypertrophy (LVH) and left ventricular diastolic dysfunction (LVDD) in newly diagnosed type 2 diabetic patients of western U;
Int J Sci Res Publ 4(12) (ISSN: 2250-3153). http://www.ijsrp.org/research-paper-1214.php?rp=P363503